Larson Financial Group LLC Raises Holdings in Agilent Technologies, Inc. (NYSE:A)

Larson Financial Group LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 33.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,088 shares of the medical research company’s stock after purchasing an additional 1,014 shares during the period. Larson Financial Group LLC’s holdings in Agilent Technologies were worth $607,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of A. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 5.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock worth $1,952,832,000 after purchasing an additional 809,149 shares during the last quarter. Marshall Wace LLP increased its stake in shares of Agilent Technologies by 48.6% during the second quarter. Marshall Wace LLP now owns 957,128 shares of the medical research company’s stock valued at $124,073,000 after buying an additional 313,155 shares during the period. Jennison Associates LLC raised its holdings in shares of Agilent Technologies by 63.3% during the third quarter. Jennison Associates LLC now owns 586,439 shares of the medical research company’s stock valued at $87,075,000 after acquiring an additional 227,431 shares in the last quarter. Impax Asset Management Group plc lifted its stake in Agilent Technologies by 8.2% in the third quarter. Impax Asset Management Group plc now owns 2,667,616 shares of the medical research company’s stock worth $396,088,000 after acquiring an additional 203,234 shares during the period. Finally, Van ECK Associates Corp boosted its holdings in Agilent Technologies by 6.6% in the third quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after acquiring an additional 183,716 shares in the last quarter.

Insider Buying and Selling

In other news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 19.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Agilent Technologies Stock Up 0.5 %

NYSE:A opened at $134.50 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The firm has a market cap of $38.65 billion, a P/E ratio of 27.90, a P/E/G ratio of 5.89 and a beta of 1.07. Agilent Technologies, Inc. has a fifty-two week low of $124.10 and a fifty-two week high of $155.35. The firm has a 50-day simple moving average of $137.82 and a two-hundred day simple moving average of $137.54.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is 19.50%.

Analyst Ratings Changes

A has been the subject of several research reports. TD Cowen upped their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Bank of America raised their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. UBS Group upped their target price on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Citigroup increased their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, Stifel Nicolaus restated a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.